Efficacy of tylex-associated to a desensitizer in tooth sensitivity induced by office bleaching

Phase 2

• Conditions: Dentin Sensitivity; C07.793.266

• Registration Number: RBR-54xy8b
• Lead Sponsor: niversidade Federal do Rio Grande do Norte

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-10-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients should be at least 18 years of age; good general and oral health; upper anterior teeth with no restorations; never bleached before.

Exclusion Criteria

Patients who present previous restorations; pregnant or breastfeeding; have discoloration of the dental element caused by trauma; severe fluorosis; darkening caused by endodontic treatment and requiring internal bleaching (non-vital); habits of bruxism or without good oral health; any previous or current health problems (in the stomach, heart, kidney and liver); continuous use of anti-inflammatory drugs and/or analgesics; systemic diseases such as diabetes, hypertension; known allergy to codeine phosphate 30mg/paracetamol 500mg.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Codeine phosphate 30mg/paracetamol 500mg administered 1 hour prior to tooth bleaching and every 6 hours for 48 hours in combination with desensitizing agent may reduce the risk and/or intensity of dental sensitivity levels induced by office bleaching.

Secondary Outcome Measures

Name	Time	Method
The coloration of the teeth will not be affected by the tested therapy of codeine phosphate 30mg/paracetamol 500mg in combination with the desensitizer, that is, the effectiveness of the whitening will be maintained.